Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Corneal Edema

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Corneal Edema in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazan, NG; Cohen, RA; Gebhardt, BM1
Birkle, DL; Sheng, Y1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Corneal Edema

ArticleYear
A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization.
    Current eye research, 1994, Volume: 13, Issue:2

    Topics: Animals; Cornea; Corneal Edema; Corneal Neovascularization; Corneal Transplantation; Diterpenes; Eosinophilia; Female; Ginkgolides; Graft Rejection; Keratitis; Lactones; Male; Platelet Activating Factor; Rabbits; Transplantation, Autologous; Transplantation, Homologous

1994
Intracamerally injected platelet activating factor (PAF) induces marked intraocular inflammatory reactions.
    Current eye research, 1992, Volume: 11, Issue:11

    Topics: Animals; Anterior Eye Segment; Aqueous Humor; Corneal Edema; Endophthalmitis; Injections; Intraocular Pressure; Platelet Activating Factor; Rabbits

1992